Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Chemo-Free Treatment With Inotuzumab Ozogamicin & Blinatumomab for Older Adults With Newly Diagnosed, Ph-, CD22+ B-ALL (Alliance A041703)"

130 views
June 20, 2023
Comments 0
Login to view comments. Click here to Login